NM_000039.3:c.200+33T>C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000039.3(APOA1):​c.200+33T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.893 in 1,612,302 control chromosomes in the GnomAD database, including 647,000 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.88 ( 59864 hom., cov: 33)
Exomes 𝑓: 0.89 ( 587136 hom. )

Consequence

APOA1
NM_000039.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.65
Variant links:
Genes affected
APOA1 (HGNC:600): (apolipoprotein A1) This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The encoded preproprotein is proteolytically processed to generate the mature protein, which promotes cholesterol efflux from tissues to the liver for excretion, and is a cofactor for lecithin cholesterolacyltransferase (LCAT), an enzyme responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein. [provided by RefSeq, Dec 2015]
APOA1-AS (HGNC:40079): (APOA1 antisense RNA)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 11-116836968-A-G is Benign according to our data. Variant chr11-116836968-A-G is described in ClinVar as [Benign]. Clinvar id is 1251605.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-116836968-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.912 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APOA1NM_000039.3 linkc.200+33T>C intron_variant Intron 3 of 3 ENST00000236850.5 NP_000030.1 P02647A0A024R3E3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APOA1ENST00000236850.5 linkc.200+33T>C intron_variant Intron 3 of 3 1 NM_000039.3 ENSP00000236850.3 P02647

Frequencies

GnomAD3 genomes
AF:
0.884
AC:
134544
AN:
152148
Hom.:
59831
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.907
Gnomad AMI
AF:
0.970
Gnomad AMR
AF:
0.820
Gnomad ASJ
AF:
0.859
Gnomad EAS
AF:
0.668
Gnomad SAS
AF:
0.684
Gnomad FIN
AF:
0.873
Gnomad MID
AF:
0.854
Gnomad NFE
AF:
0.918
Gnomad OTH
AF:
0.878
GnomAD3 exomes
AF:
0.849
AC:
212034
AN:
249616
Hom.:
91128
AF XY:
0.845
AC XY:
114482
AN XY:
135410
show subpopulations
Gnomad AFR exome
AF:
0.900
Gnomad AMR exome
AF:
0.798
Gnomad ASJ exome
AF:
0.861
Gnomad EAS exome
AF:
0.689
Gnomad SAS exome
AF:
0.697
Gnomad FIN exome
AF:
0.879
Gnomad NFE exome
AF:
0.918
Gnomad OTH exome
AF:
0.870
GnomAD4 exome
AF:
0.893
AC:
1304481
AN:
1460036
Hom.:
587136
Cov.:
37
AF XY:
0.887
AC XY:
644609
AN XY:
726430
show subpopulations
Gnomad4 AFR exome
AF:
0.904
Gnomad4 AMR exome
AF:
0.801
Gnomad4 ASJ exome
AF:
0.862
Gnomad4 EAS exome
AF:
0.625
Gnomad4 SAS exome
AF:
0.699
Gnomad4 FIN exome
AF:
0.880
Gnomad4 NFE exome
AF:
0.924
Gnomad4 OTH exome
AF:
0.880
GnomAD4 genome
AF:
0.884
AC:
134632
AN:
152266
Hom.:
59864
Cov.:
33
AF XY:
0.876
AC XY:
65199
AN XY:
74442
show subpopulations
Gnomad4 AFR
AF:
0.907
Gnomad4 AMR
AF:
0.820
Gnomad4 ASJ
AF:
0.859
Gnomad4 EAS
AF:
0.668
Gnomad4 SAS
AF:
0.684
Gnomad4 FIN
AF:
0.873
Gnomad4 NFE
AF:
0.918
Gnomad4 OTH
AF:
0.874
Alfa
AF:
0.909
Hom.:
66514
Bravo
AF:
0.888
Asia WGS
AF:
0.681
AC:
2374
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 30, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Hypoalphalipoproteinemia, primary, 2, intermediate Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hypoalphalipoproteinemia, primary, 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Familial visceral amyloidosis, Ostertag type Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.28
DANN
Benign
0.35
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2070665; hg19: chr11-116707684; API